Ketan Paranjape is the General Manager Life Sciences and Analytics in the Health Strategy and Solutions Group at Intel Corporation. His role involves managing and partnering with a worldwide cross-Intel team from various business units, Sales and Marketing, Global Public Policy, Corporate Affairs, and Intel Labs to develop Life Sciences and Healthcare Analytics strategies and solutions for health and life sciences customers, managing and driving results for multiple, simultaneous projects inside and outside of Intel that cover a wide range of topics from technology assessment to solution blueprints to public policy to innovation processes. With a background in data sciences and bioinformatics, he currently runs a corporate wide Big Data Analytics in Health and Life Sciences program where he is partnering with cross-Intel teams, academic medical centers, OEMs, ODMs, and ISVs to develop market and research specific solutions for payers, providers, governments, life sciences and pharmaceuticals R&D with the goal of delivering “Personalized Medicine at the touch of a button… Everywhere… Everyday… and For Everyone…”. More details on his work can be found at www.intel.com/healthcare/bigdata. In his 17 years at Intel Corp, he has been part of products spanning the entire “Compute Continuum” from high performance computing (HPC) to embedded medical devices in roles encompassing architecture, R&D, strategy, planning, sales and marketing. He has spent 3 years in Intel Research as the Chief of Staff and Technical Advisor to the Intel Chief Technology Officer. He also had a stint at the International Telecommunications Union (ITU) leading a high level experts group to create technical and procedural specifications for Cyber-Security. He is currently a faculty member at the International Institute for Analytics and teaches regularly at the Harvard School of Public Health.